Bronchopulmonary Dysplasia Market Report

Global and Region Bronchopulmonary Dysplasia Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：214
  • REPORT CODE：GMM1022547
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Bronchopulmonary dysplasia, a type of chronic lung disorder, affects newborns, mostly premature and infants. Lungs and bronchi are damaged at the neonatal phase which causes destruction of tiny air sacs known as alveoli. Babies are not born with the disease. The condition is developed when premature infants need aid to breathe for a longer period, leading to inflammation and lung scarring. Infants with this disease exhibit signs and symptoms such as rapid breathing and faster heart rate. The disease is life threatening however, the severity of the disease varies.

    The report details the trend, potential and market size of Bronchopulmonary Dysplasia market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Bronchopulmonary Dysplasiamarket, defines the market attractiveness level of Bronchopulmonary Dysplasia market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Bronchopulmonary Dysplasia industry, describes the types of Bronchopulmonary Dysplasia market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bronchopulmonary Dysplasia market and the development prospects and opportunities of Bronchopulmonary Dysplasia industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bronchopulmonary Dysplasia market in Chapter 13.

    By Player:

    • Medipost

    • Martindale Pharmaceuticals

    • Meridigen Biotech

    • Shire

    • Insmed Inc

    • Therabron Therapeutics

    • Takeda Pharmaceutical Company

    • Clarassance, Inc

    • Discovery Laboratories, Inc

    • Windtree Therapeutics

    • Chiesi Farmaceutici SpA

    • Syntrix Biosystems, Inc

    • Ikaria, Inc

    • Airway Therapeutics, LLC

    By Type:

    • Surfactant Replacement Therapy

    • Oxygen Therapy

    • Supportive Therapy

    • Others

    By End-User:

    • Clinic

    • Hospital

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Bronchopulmonary Dysplasia Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Bronchopulmonary Dysplasia Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Bronchopulmonary Dysplasia Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Bronchopulmonary Dysplasia Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Bronchopulmonary Dysplasia Market Analysis and Outlook to 2022

    • 7.1 Global Bronchopulmonary Dysplasia Consumption (2017-2022)

    • 7.2 United States Bronchopulmonary Dysplasia Consumption (2017-2022)

    • 7.3 Europe Bronchopulmonary Dysplasia Consumption (2017-2022)

    • 7.4 China Bronchopulmonary Dysplasia Consumption (2017-2022)

    • 7.5 Japan Bronchopulmonary Dysplasia Consumption (2017-2022)

    • 7.6 India Bronchopulmonary Dysplasia Consumption (2017-2022)

    • 7.7 South Korea Bronchopulmonary Dysplasia Consumption (2017-2022)

    8 Region and Country-wise Bronchopulmonary Dysplasia Market Analysis and Outlook to 2028

    • 8.1 Global Bronchopulmonary Dysplasia Consumption Forecast (2022-2028)

    • 8.2 United States Bronchopulmonary Dysplasia Consumption Forecast (2022-2028)

    • 8.3 Europe Bronchopulmonary Dysplasia Consumption Forecast (2022-2028)

    • 8.4 China Bronchopulmonary Dysplasia Consumption Forecast (2022-2028)

    • 8.5 Japan Bronchopulmonary Dysplasia Consumption Forecast (2022-2028)

    • 8.6 India Bronchopulmonary Dysplasia Consumption Forecast (2022-2028)

    • 8.7 South Korea Bronchopulmonary Dysplasia Consumption Forecast (2022-2028)

    9 Global Bronchopulmonary Dysplasia Market Outlook by Types and Applications to 2022

    • 9.1 Global Bronchopulmonary Dysplasia Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Surfactant Replacement Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Oxygen Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Supportive Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Bronchopulmonary Dysplasia Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Bronchopulmonary Dysplasia Market Outlook by Types and Applications to 2028

    • 10.1 Global Bronchopulmonary Dysplasia Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Surfactant Replacement Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Oxygen Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Supportive Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Bronchopulmonary Dysplasia Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Bronchopulmonary Dysplasia Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Bronchopulmonary Dysplasia Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Bronchopulmonary Dysplasia Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Bronchopulmonary Dysplasia Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Bronchopulmonary Dysplasia Market Competitive Analysis

    • 14.1 Medipost

      • 14.1.1 Medipost Company Details

      • 14.1.2 Medipost Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Medipost Bronchopulmonary Dysplasia Product and Service

    • 14.2 Martindale Pharmaceuticals

      • 14.2.1 Martindale Pharmaceuticals Company Details

      • 14.2.2 Martindale Pharmaceuticals Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Martindale Pharmaceuticals Bronchopulmonary Dysplasia Product and Service

    • 14.3 Meridigen Biotech

      • 14.3.1 Meridigen Biotech Company Details

      • 14.3.2 Meridigen Biotech Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Meridigen Biotech Bronchopulmonary Dysplasia Product and Service

    • 14.4 Shire

      • 14.4.1 Shire Company Details

      • 14.4.2 Shire Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Shire Bronchopulmonary Dysplasia Product and Service

    • 14.5 Insmed Inc

      • 14.5.1 Insmed Inc Company Details

      • 14.5.2 Insmed Inc Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Insmed Inc Bronchopulmonary Dysplasia Product and Service

    • 14.6 Therabron Therapeutics

      • 14.6.1 Therabron Therapeutics Company Details

      • 14.6.2 Therabron Therapeutics Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Therabron Therapeutics Bronchopulmonary Dysplasia Product and Service

    • 14.7 Takeda Pharmaceutical Company

      • 14.7.1 Takeda Pharmaceutical Company Company Details

      • 14.7.2 Takeda Pharmaceutical Company Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Takeda Pharmaceutical Company Bronchopulmonary Dysplasia Product and Service

    • 14.8 Clarassance, Inc

      • 14.8.1 Clarassance, Inc Company Details

      • 14.8.2 Clarassance, Inc Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Clarassance, Inc Bronchopulmonary Dysplasia Product and Service

    • 14.9 Discovery Laboratories, Inc

      • 14.9.1 Discovery Laboratories, Inc Company Details

      • 14.9.2 Discovery Laboratories, Inc Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Discovery Laboratories, Inc Bronchopulmonary Dysplasia Product and Service

    • 14.10 Windtree Therapeutics

      • 14.10.1 Windtree Therapeutics Company Details

      • 14.10.2 Windtree Therapeutics Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Windtree Therapeutics Bronchopulmonary Dysplasia Product and Service

    • 14.11 Chiesi Farmaceutici SpA

      • 14.11.1 Chiesi Farmaceutici SpA Company Details

      • 14.11.2 Chiesi Farmaceutici SpA Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Chiesi Farmaceutici SpA Bronchopulmonary Dysplasia Product and Service

    • 14.12 Syntrix Biosystems, Inc

      • 14.12.1 Syntrix Biosystems, Inc Company Details

      • 14.12.2 Syntrix Biosystems, Inc Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Syntrix Biosystems, Inc Bronchopulmonary Dysplasia Product and Service

    • 14.13 Ikaria, Inc

      • 14.13.1 Ikaria, Inc Company Details

      • 14.13.2 Ikaria, Inc Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Ikaria, Inc Bronchopulmonary Dysplasia Product and Service

    • 14.14 Airway Therapeutics, LLC

      • 14.14.1 Airway Therapeutics, LLC Company Details

      • 14.14.2 Airway Therapeutics, LLC Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Airway Therapeutics, LLC Bronchopulmonary Dysplasia Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Bronchopulmonary Dysplasia

    • Figure Bronchopulmonary Dysplasia Picture

    • Table Global Bronchopulmonary Dysplasia Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Bronchopulmonary Dysplasia Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Bronchopulmonary Dysplasia Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Bronchopulmonary Dysplasia Consumption by Country (2017-2022)

    • Figure United States Bronchopulmonary Dysplasia Consumption and Growth Rate (2017-2022)

    • Table Europe Bronchopulmonary Dysplasia Consumption and Growth Rate (2017-2022)

    • Figure China Bronchopulmonary Dysplasia Consumption and Growth Rate (2017-2022)

    • Figure Japan Bronchopulmonary Dysplasia Consumption and Growth Rate (2017-2022)

    • Figure India Bronchopulmonary Dysplasia Consumption and Growth Rate (2017-2022)

    • Figure South Korea Bronchopulmonary Dysplasia Consumption and Growth Rate (2017-2022)

    • Figure Global Bronchopulmonary Dysplasia Consumption Forecast by Country (2022-2028)

    • Figure United States Bronchopulmonary Dysplasia Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Bronchopulmonary Dysplasia Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Bronchopulmonary Dysplasia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Bronchopulmonary Dysplasia Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Bronchopulmonary Dysplasia Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Bronchopulmonary Dysplasia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Surfactant Replacement Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Oxygen Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Supportive Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Surfactant Replacement Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oxygen Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Supportive Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Bronchopulmonary Dysplasia Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Bronchopulmonary Dysplasia Export by Region (Top 5 Countries) (2017-2028)

    • Table Medipost (Foundation Year, Company Profile and etc.)

    • Table Medipost Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medipost Bronchopulmonary Dysplasia Product and Service

    • Table Martindale Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Martindale Pharmaceuticals Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

    • Table Martindale Pharmaceuticals Bronchopulmonary Dysplasia Product and Service

    • Table Meridigen Biotech (Foundation Year, Company Profile and etc.)

    • Table Meridigen Biotech Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

    • Table Meridigen Biotech Bronchopulmonary Dysplasia Product and Service

    • Table Shire (Foundation Year, Company Profile and etc.)

    • Table Shire Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Bronchopulmonary Dysplasia Product and Service

    • Table Insmed Inc (Foundation Year, Company Profile and etc.)

    • Table Insmed Inc Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

    • Table Insmed Inc Bronchopulmonary Dysplasia Product and Service

    • Table Therabron Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Therabron Therapeutics Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

    • Table Therabron Therapeutics Bronchopulmonary Dysplasia Product and Service

    • Table Takeda Pharmaceutical Company (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceutical Company Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Company Bronchopulmonary Dysplasia Product and Service

    • Table Clarassance, Inc (Foundation Year, Company Profile and etc.)

    • Table Clarassance, Inc Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

    • Table Clarassance, Inc Bronchopulmonary Dysplasia Product and Service

    • Table Discovery Laboratories, Inc (Foundation Year, Company Profile and etc.)

    • Table Discovery Laboratories, Inc Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

    • Table Discovery Laboratories, Inc Bronchopulmonary Dysplasia Product and Service

    • Table Windtree Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Windtree Therapeutics Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

    • Table Windtree Therapeutics Bronchopulmonary Dysplasia Product and Service

    • Table Chiesi Farmaceutici SpA (Foundation Year, Company Profile and etc.)

    • Table Chiesi Farmaceutici SpA Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chiesi Farmaceutici SpA Bronchopulmonary Dysplasia Product and Service

    • Table Syntrix Biosystems, Inc (Foundation Year, Company Profile and etc.)

    • Table Syntrix Biosystems, Inc Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

    • Table Syntrix Biosystems, Inc Bronchopulmonary Dysplasia Product and Service

    • Table Ikaria, Inc (Foundation Year, Company Profile and etc.)

    • Table Ikaria, Inc Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ikaria, Inc Bronchopulmonary Dysplasia Product and Service

    • Table Airway Therapeutics, LLC (Foundation Year, Company Profile and etc.)

    • Table Airway Therapeutics, LLC Bronchopulmonary Dysplasia Sales, Price, Value and Gross Profit (2017-2022)

    • Table Airway Therapeutics, LLC Bronchopulmonary Dysplasia Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US